Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 
 

Life Sciences

full industries list
Life Sciences Image
News
Events
Litigation Blog
Hatch-Waxman

Fish attorneys have served as leading advisors to pioneers in the pharmaceutical, biotechnology, and life sciences fields for more than a century. For three consecutive years, we have been named the top US law firm for life sciences and biotechnology IP work by Managing Intellectual Property magazine. Clients choose Fish because of the technical and scientific expertise of our internationally recognized attorneys.

Large and small companies, along with academic and research institutions, turn to Fish’s team to protect their most valuable innovations. We offer biotechnology and pharmaceutical clients services that include:

  • Patent portfolio planning, strategic advice, opinions, and prosecution
  • Post-grant proceedings at the USPTO
  • Litigation services, including representation in Hatch-Waxman cases
  • FDA expertise
  • Counsel on licensing and other transactions

We have a rapidly expanding practice representing branded pharmaceutical companies in Hatch-Waxman litigation. Biotechnology and pharmaceutical companies trust Fish’s litigation team to handle these complicated, high-stakes cases because we are the world’s most experienced patent litigators.

Examples of our biotechnology and pharmaceutical work include:

  • Representing dozens of biotechnology and pharmaceutical clients in patent infringement litigation
  • Successfully litigating ANDA cases on behalf of branded pharmaceuticals
  • Obtaining patents for therapeutic agents and methods currently in clinical trials, including tumor-specific agents such as oncolytics viruses and humanized antibodies and methods for treating strokes
  • Patenting groundbreaking tissue engineering patents on breakthroughs that show promise in treating spinal cord injuries
  • Obtaining the first patent on a genetically engineered animal
  • Gaining FDA approvals for small molecule drugs and biologics, including gene and cell therapies, antibiotics, immunologics, and anti-anxiety medications
  • Conducting intellectual property due diligence on thousands of licensing agreements for the merger of two large pharmaceuticals companies in just a few months’ time

Upcoming Webinars

Tuesday, May 23, 2017
1:00 PM EST

Webinar - BCPIA Guidance

Recent and Upcoming BPCIA Guidance from the Federal Circuit and the Supreme Court

Featured Video
A Conversation with Life Science Litigator Jonathan Singer

Featured Video
Principal, Gwilym Attwell Discusses Life Science Intellectual Property

Featured Experience

Search Fish Team

Search by Letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
No matches
Life Sciences

Life Sciences Team

What's Trending in Life Sciences

Filter by
Fish Patent Blog
June 19, 2017
Teresa Lavoie Interviewed by Metropolitan Corporate Counsel, "How a Patent Prosecutor/Strategic Adviser Racks Up Wins"
Teresa Lavoie Interviewed by <i>Metropolitan Corporate Counsel</i>,
Author: Teresa A. Lavoie, Ph.D.
Fish Patent Blog
June 14, 2017
Tasha Francis, Will Orlady and Dorothy Whelan Author NYIPLA Article, "Recent Developments in Biopharma PTAB Practice"
Tasha Francis, Will Orlady and Dorothy Whelan Author <i>NYIPLA</i> Article,
Authors: Will Orlady, Dorothy P. Whelan, Tasha M. Francis, Ph.D.
News
June 13, 2017
PTAB Rules in Favor of Fish Client Coherus BioSciences in Two More IPR Decisions
Articles
Fish Patent Blog
May 23, 2017
Xconomy: What's Hot in Boston Biotech
Xconomy: What's Hot in Boston Biotech
Author: Teresa A. Lavoie, Ph.D.
News
May 19, 2017
Uncertainty In Patent Term Extension For Biologics
Articles
Event
June 24th, 2017
Betty Chen to Speak at 2017 BioPacific Conference
Betty Chen to Speak at 2017 BioPacific Conference
Speaking Engagement
News
May 17, 2017
Fish Client Coherus BioSciences Prevails in ‘135 IPR Decision
Press Release
News
May 3, 2017
Terry Mahn Quoted in Biosimilar Development Article, "Surveying The Current Legal Landscape For Biosimilars"
Media Mention
News
May 3, 2017
Two Fish & Richardson Attorneys Named to "2017 Best Attorneys" List
Press Release
News
April 27, 2017
Terry Mahn Quoted in Biosimilar Development Article, "Amgen Vs. Sandoz: Who Will Win Over The Supreme Court?"
Media Mention
News
March 31, 2017
A Big Year Is Expected in Life Sciences Patent Litigation
Media Mention
Q&A
March 22, 2017
Q&A with Chad Shear: A Big Year Is Expected in Life Sciences Patent Litigation
Q&A - Chad Shear
Author: W. Chad Shear
Hatch-Waxman
Life Sciences
Litigation
Patent
Non-Practicing Entities
IP
Trends
load more topics